ENDURANT CAPITAL MANAGEMENT LP Global Blood Therapeutics, Inc. Transaction History

ENDURANT CAPITAL MANAGEMENT LP portfolio value:

$0
portfolio value

ENDURANT CAPITAL MANAGEMENT LP quarter portfolio value change:

+113.15%
quarter

Global Blood Therapeutics, Inc. 13F transactions

Quarter Transaction type Change Relative change Absolute change Change value Avg. price Shares
Q3 2022 share Decrease -100.00% -81.00K shares -2.58M $68.1 0
Q2 2022 share Increase +87.30% 37.75K shares 1.09M $31.95 81.00K
Q1 2022 share Increase +1.06% 453 shares 245K $34.64 43.25K
Q4 2021 share Increase 0.00% 42.79K shares 1.25M $29.86 42.79K